LAMANUZZI, AURELIA
 Distribuzione geografica
Continente #
NA - Nord America 1.148
EU - Europa 244
AS - Asia 97
SA - Sud America 2
OC - Oceania 1
Totale 1.492
Nazione #
US - Stati Uniti d'America 1.147
SE - Svezia 107
CN - Cina 73
IT - Italia 62
FR - Francia 15
VN - Vietnam 15
GB - Regno Unito 14
DE - Germania 13
FI - Finlandia 13
BE - Belgio 10
IE - Irlanda 5
IN - India 5
CL - Cile 2
IR - Iran 2
UA - Ucraina 2
AU - Australia 1
BY - Bielorussia 1
CA - Canada 1
IL - Israele 1
LB - Libano 1
LU - Lussemburgo 1
PL - Polonia 1
Totale 1.492
Città #
Fairfield 148
Chandler 143
Ashburn 120
Woodbridge 114
Nyköping 98
Seattle 66
Cambridge 65
Wilmington 64
Houston 62
Ann Arbor 53
New York 48
Bari 29
Beijing 27
Lawrence 22
Roxbury 21
Nanjing 19
Dong Ket 15
Brooklyn 11
Des Moines 11
San Diego 11
Brussels 10
Dearborn 10
Inglewood 10
Helsinki 9
Jacksonville 9
Marseille 7
Princeton 7
Washington 7
Dublin 5
Paris 5
Grafing 4
Jiaxing 4
Los Angeles 4
Rome 4
Boardman 3
Hebei 3
London 3
Nanchang 3
Redwood City 3
Suri 3
Ardabil 2
Augusta 2
Guangzhou 2
Jinan 2
Kunming 2
Pune 2
Reggio Calabria 2
Santiago 2
Tianjin 2
Acton 1
Barletta 1
Changsha 1
Cincinnati 1
Ergolding 1
Falkenstein 1
Hefei 1
Kilburn 1
Luxembourg 1
Markham 1
Milan 1
Minsk 1
Modugno 1
Nagold 1
New Bedfont 1
Redmond 1
San Francisco 1
San Mateo 1
Sankt Augustin 1
Shenyang 1
Shenzhen 1
Southend 1
Sydney 1
Taizhou 1
Talsano 1
Tamm 1
Tappahannock 1
Trani 1
Totale 1.306
Nome #
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 126
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 116
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 109
Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies 105
Identify multiple myeloma stem cells: Utopia? 103
null 101
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 93
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 82
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 79
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 76
Inhibition of endothelial and plasma cells NOTCH mediated comunication reduces angiogenesis in multiple myeloma patients. 59
The role of SIRT6 in tumors 54
Inhibition of Notch mediated communication in endothelial and plasma cells reduces angiogenesis in multiple myeloma patients. 48
null 43
Inhibition of Notch-mediated crosstalk between endothelial cells and plasmacells reduces angiogenesis in multiple myeloma patients. 40
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 36
Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma 36
null 31
null 30
Myeloma cells regulate {miRNA} transfer from fibroblast-derived exosomes by expression of {lncRNAs} 30
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 25
Antiangiogenic drugs as chemosensitizers in hematological tumors 24
The “angiogenic switch” from MGUS to MM: what about the Notch role? 23
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 22
Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma 22
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 21
The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities 20
Cardiovascular Risk in Patients With Takayasu Arteritis Directly Correlates With Diastolic Dysfunction and Inflammatory Cell Infiltration in the Vessel Wall: A Clinical, ex vivo and in vitro Analysis 18
Notch cross-talk between endothelial cells and plasma cells in bone marrow of multiple myeloma patients 11
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 10
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance 9
Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives 9
Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression 8
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 6
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance 6
Totale 1.631
Categoria #
all - tutte 7.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.710


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201972 0 0 0 0 0 0 0 0 0 0 37 35
2019/2020358 43 12 14 25 28 35 40 41 42 29 34 15
2020/2021332 11 11 18 21 66 23 25 29 24 47 28 29
2021/2022187 16 8 5 7 5 13 10 11 17 15 26 54
2022/2023378 36 66 33 29 27 50 7 48 58 8 8 8
2023/2024187 10 22 12 13 26 80 3 11 4 6 0 0
Totale 1.631